PSYENCE BIOMEDICAL LTD.

TORONTO, A6 · Founded 2023 · CIK 0001985062 · Biotech · Public

Psilocybin-based therapeutics for mental health disorders

psyence.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$2.0M
1 Form D · Jan 2025
21 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$2,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2157Bitterroot Bio——
2158ASL Analytical, Inc.—$2.4M
2159NOVAZOI THERANOSTICS——
2160PSYENCE BIOMEDICAL LTD.—$2.0M
2161MITORAINBOW THERAPEUTICS, INC.——
2162Avanti Biosciences Inc——
2163VAXCYTE, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Jody AufrichtigDirector · Executive Officer
  • Marc BalkinDirector
  • Bull ChristopherDirector
  • Warwick Corden-LloydExecutive Officer
  • Dr. Seth FeuersteinDirector
  • Neil MareskyDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.